{"id":2826,"date":"2021-11-30T10:05:57","date_gmt":"2021-11-30T09:05:57","guid":{"rendered":"https:\/\/wp.idlbiotech.com\/?page_id=2826"},"modified":"2025-05-27T10:57:15","modified_gmt":"2025-05-27T08:57:15","slug":"articles-of-association","status":"publish","type":"page","link":"https:\/\/idldiagnostics.com\/se\/investors\/corporate-governance\/articles-of-association\/","title":{"rendered":"Bolagsordning"},"content":{"rendered":"

[et_pb_section fb_built=”1″ _builder_version=”4.18.0″ _module_preset=”88f366a5-bf49-48d9-a338-ab22706b73e7″ global_colors_info=”{}”][et_pb_row _builder_version=”4.18.0″ _module_preset=”default” custom_padding=”0px||0px|||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” custom_padding=”||||false|false” custom_padding_tablet=”10px||||false|false” custom_padding_phone=”0px||||false|false” custom_padding_last_edited=”on|phone” global_colors_info=”{}”][dipi_breadcrumbs _builder_version=”4.27.4″ _module_preset=”default” max_width=”800px” global_module=”5132″ global_colors_info=”{}”][\/dipi_breadcrumbs][et_pb_divider color=”#EEEEEE” _builder_version=”4.16″ _module_preset=”default” max_width=”800px” min_height=”1px” height=”20px” custom_margin=”||3px|||” global_colors_info=”{}”][\/et_pb_divider][et_pb_text _builder_version=”4.16″ _module_preset=”8738c908-7375-4c6c-99a7-9f91f8a3c099″ header_font_size=”56px” max_width=”800px” custom_margin=”||17px|||” global_colors_info=”{}”]<\/p>\n

Articles of association<\/h6>\n

Articles of association.<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.18.0″ _module_preset=”e9afc0e7-c9bf-4a12-be49-63ddba231101″ global_colors_info=”{}”][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” max_width=”800px” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n

Org. No. 556596-6107<\/h2>\n

Adopted at the AGM 15 May 2025.<\/h2>\n

(Available in Swedish only)<\/h4>\n

\u00a71 F\u00f6retagsnamn<\/strong>
Bolagets f\u00f6retagsnamn \u00e4r IDL Diagnostics AB (publ).<\/p>\n

\u00a72 Styrelsens s\u00e4te<\/strong>
Styrelsen skall ha sitt s\u00e4te i Stockholms kommun.<\/p>\n

\u00a73 Verksamhet
<\/strong>Bolaget ska direkt eller indirekt genom dotterbolag eller andra intressebolag bedrivs forsknings-, utvecklings- och tillverkningsarbete samt handel och f\u00f6rs\u00e4ljning av produkter och tj\u00e4nster inom omr\u00e5dena cellbiologi, medicinteknik och diagnostik j\u00e4mte med detta f\u00f6renlig verksamhet.<\/p>\n

\u00a7 4 Aktiekapital<\/strong>
Aktiekapitalet ska uppg\u00e5 till l\u00e4gst 22 500 000 kronor och h\u00f6gst 90 000 000 kronor.<\/p>\n

\u00a7 5 Antal aktier
<\/strong>Antalet aktier ska uppg\u00e5 till l\u00e4gst 225 000 000 och h\u00f6gst 900 000 000.<\/p>\n

\u00a7 6 R\u00e4kenskaps\u00e5r
<\/strong>Bolagets r\u00e4kenskaps\u00e5r skall vara kalender\u00e5r.<\/p>\n

\u00a7 7 Styrelsen<\/strong>
Styrelsen skall best\u00e5 av l\u00e4gst tre och h\u00f6gst \u00e5tta ledam\u00f6ter med h\u00f6gst tre suppleanter. Ledam\u00f6terna och suppleanterna v\u00e4ljs \u00e5rligen p\u00e5 \u00e5rsst\u00e4mma f\u00f6r tiden intill slutet av n\u00e4sta \u00e5rsst\u00e4mma.<\/p>\n

\u00a7 8 Revisor
<\/strong>F\u00f6r granskning av bolagets \u00e5rsredovisning j\u00e4mte r\u00e4kenskaperna samt styrelsens och verkst\u00e4llande direkt\u00f6rens f\u00f6rvaltning ska en eller tv\u00e5 revisorer utses p\u00e5 st\u00e4mman. Till revisor kan \u00e4ven utses ett registrerat revisionsbolag.<\/p>\n

\u00a7 9 \u00c5rsst\u00e4mma<\/strong>
P\u00e5 \u00e5rsst\u00e4mma ska f\u00f6ljande \u00e4renden f\u00f6rekomma.<\/p>\n

1. Val av ordf\u00f6rande vid st\u00e4mman
2. Uppr\u00e4ttande och godk\u00e4nnande av r\u00f6stl\u00e4ngd
3. Val av en eller tv\u00e5 justeringspersoner
4. Pr\u00f6vning om st\u00e4mman blivit beh\u00f6rigen sammankallad
5. Godk\u00e4nnande av dagordningen
6. Framl\u00e4ggande av \u00e5rsredovisning och revisionsber\u00e4ttelse samt, i f\u00f6rekommande fall, koncernredovisning och koncernrevisionsber\u00e4ttelse
7. Beslut om:<\/p>\n

a. fastst\u00e4llelse av resultatr\u00e4kning och balansr\u00e4kning samt, i f\u00f6rekommande fall, koncernresultatr\u00e4kning och koncernbalansr\u00e4kning<\/p>\n

b. dispositioner betr\u00e4ffande bolagets vinst eller f\u00f6rlust enligt den fastst\u00e4llda balansr\u00e4kningen; och<\/p>\n

c. ansvarsfrihet \u00e5t styrelseledam\u00f6ter och verkst\u00e4llande direkt\u00f6ren<\/p>\n

8. Fastst\u00e4llande av arvoden \u00e5t styrelse och revisorn\/revisorerna
9. Val till styrelsen samt av revisor\/er
10. Annat \u00e4rende, som ankommer p\u00e5 st\u00e4mman enligt aktiebolagslagen (2005:551) eller bolagsordningen.<\/p>\n

<\/strong><\/p>\n

\u00a7 10 Anm\u00e4lan till st\u00e4mma
<\/strong>En aktie\u00e4gare f\u00e5r delta i bolagsst\u00e4mma endast om aktie\u00e4garen anm\u00e4ler detta till bolaget senast den dag som anges i kallelsen till st\u00e4mman. Sistn\u00e4mnda dag f\u00e5r inte vara s\u00f6ndag, annan allm\u00e4n helgdag, l\u00f6rdag, midsommarafton, julafton eller ny\u00e5rsafton och inte infalla tidigare \u00e4n femte vardagen f\u00f6re st\u00e4mman.<\/p>\n

En aktie\u00e4gare f\u00e5r ha med sig bitr\u00e4den vid bolagsst\u00e4mman endast om aktie\u00e4garen anm\u00e4ler antalet bitr\u00e4den (h\u00f6gst tv\u00e5) till bolaget p\u00e5 det s\u00e4tt som anges i f\u00f6reg\u00e5ende stycke.<\/p>\n

\u00a711 Kallelse<\/strong>
Kallelse till bolagsst\u00e4mma skall ske genom annonsering i Post- och Inrikes Tidningar och genom att kallelsen h\u00e5lls tillg\u00e4nglig p\u00e5 bolagets webbplats. Samtidigt som kallelse sker skall bolaget genom annonsering i Dagens Industri upplysa om att kallelse har skett.<\/p>\n

\u00a7 12 Insamling av fullmakter och postr\u00f6stning
<\/strong>Styrelsen f\u00e5r samla in fullmakter enligt det f\u00f6rfarande som anges i 7 kap. 4 \u00a7 andra stycket aktiebolagslagen (2005:551).<\/p>\n

Styrelsen f\u00e5r inf\u00f6r en bolagsst\u00e4mma besluta att aktie\u00e4garna ska kunna ut\u00f6va sin r\u00f6str\u00e4tt per post f\u00f6re bolagsst\u00e4mman. Postr\u00f6stning skall om styrelsen s\u00e5 beslutar kunna ske med elektroniska medel.<\/p>\n

\u00a7 13 Utomst\u00e5endes n\u00e4rvaro vid bolagsst\u00e4mma
<\/strong>Styrelsen f\u00e5r besluta att den som inte \u00e4r aktie\u00e4gare i bolaget ska, p\u00e5 de villkor som styrelsen best\u00e4mmer, ha r\u00e4tt att n\u00e4rvara eller p\u00e5 annat s\u00e4tt f\u00f6lja f\u00f6rhandlingarna vid en bolagsst\u00e4mma.<\/p>\n

\u00a7 14 Avst\u00e4mningsf\u00f6rbeh\u00e5ll
<\/strong>Bolagets aktier skall vara registrerade i ett avst\u00e4mningsregister enligt lagen (1998:1479) om v\u00e4rdepapperscentraler och kontof\u00f6ring av finansiella instrument.<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=”4.16″ _module_preset=”default” global_module=”3466″ saved_tabs=”all” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_menu menu_id=”29″ disabled_on=”on|on|off” _builder_version=”4.18.0″ _module_preset=”default” background_color=”#F8F8F8″ global_colors_info=”{}”][\/et_pb_menu][et_pb_sidebar area=”et_pb_widget_area_2″ disabled_on=”off|off|on” _builder_version=”4.16″ _module_preset=”2efbbc8f-7ecb-4fe3-9956-d83a8a0e7a74″ background_color=”#F8F8F8″ global_colors_info=”{}”][\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” _builder_version=”4.9.4″ _module_preset=”default” custom_margin_tablet=”||||false|false” custom_margin_phone=”” custom_margin_last_edited=”on|tablet” custom_padding_tablet=”||0px||false|false” custom_padding_phone=”” global_module=”2177″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” text_text_color=”#21242A” global_colors_info=”{}”]<\/p>\n

About us<\/h6>\n

We provide knowledge to decision.<\/h3>\n

IDL Diagnosticsis a Swedish diagnostics company with the vision to improve the monitoring of oncological and bacterial diseases. We have a broad product portfolio of IVD tests that deliver high-value clinical information for the detection of diseases.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/idldiagnostics.com\/about-arocell\/” button_text=”Read more about us” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/MG_7941-800.jpg” title_text=”MG_7941-600″ src_tablet=”” src_phone=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2023\/08\/MG_7941-600.jpg” src_last_edited=”on|phone” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” _builder_version=”4.16″ _module_preset=”default” custom_padding_tablet=”||0px||false|false” custom_padding_phone=”” global_module=”2428″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Bacteriology<\/h6>\n

An effective typhoid test<\/h3>\n

Typhoid fever is water and food-borne infectious disease caused by the bacterium, Salmonella<\/em> enterica. IDL Biotechs product TUBEX\u00ae TF, is a rapid and sensitive in vitro diagnostic test for the detection of acute typhoid fever.<\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/idldiagnostics.com\/products\/bacteriology\/” button_text=”Read more about bacteriology” _builder_version=”4.18.0″ _module_preset=”5e8c1032-9074-49bb-92a6-99c20ecc3d02″ global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/girl-water.jpeg” title_text=”Water is Life for African Children, Little Gorgeous Black Girl Drinking from Tap” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” _builder_version=”4.16″ _module_preset=”default” custom_padding_tablet=”||0px||false|false” custom_padding_phone=”” global_module=”2365″ saved_tabs=”all” global_colors_info=”{}”][et_pb_row column_structure=”1_2,1_2″ _builder_version=”4.22.1″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”]<\/p>\n

Oncology<\/h6>\n

Diagnostics for oncology<\/h3>\n

Cancer is one of the leading causes of death worldwide, despite advancing knowledge. To improve cancer patient management, there is a clear need for efficient diagnostics tools to capture this critical clinical data.<\/span><\/p>\n

[\/et_pb_text][et_pb_button button_url=”https:\/\/idldiagnostics.com\/products\/oncology\/” button_text=”Read more about oncology” _builder_version=”4.22.1″ _module_preset=”5e8c1032-9074-49bb-92a6-99c20ecc3d02″ global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][et_pb_column type=”1_2″ _builder_version=”4.16″ _module_preset=”default” global_colors_info=”{}”][et_pb_image src=”https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/girl-sunset.jpeg” title_text=”Happy smiling running beagle dog portrait with tongue out and owner female jogging by the mounting meadow grass path. Walking in nature with pets, happy healthy active people lifestyle concept image.” _builder_version=”4.18.0″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t
\n\t\t\t\t\t
\n